BKDT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 18 cases where BKDT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on December 10, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on BKDT as a result. In of 30 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for BKDT turned negative on December 16, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 20 similar instances when the indicator turned negative. In of the 20 cases the stock turned lower in the days that followed. This puts the odds of success at .
The Aroon Indicator for BKDT entered a downward trend on December 12, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (4.577). P/E Ratio (0.000) is within average values for comparable stocks, (71.885). BKDT's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.595). Dividend Yield (0.045) settles around the average of (0.026) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (21.067).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BKDT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BKDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Industry MedicalNursingServices
A.I.dvisor indicates that over the last year, BKDT has been loosely correlated with BKD. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if BKDT jumps, then BKD could also see price increases.
Ticker / NAME | Correlation To BKDT | 1D Price Change % | ||
---|---|---|---|---|
BKDT | 100% | N/A | ||
BKD - BKDT | 58% Loosely correlated | +2.60% | ||
CYH - BKDT | 25% Poorly correlated | +3.95% | ||
JYNT - BKDT | 23% Poorly correlated | -0.19% | ||
CCRN - BKDT | 23% Poorly correlated | -0.06% | ||
HCSG - BKDT | 21% Poorly correlated | -1.22% | ||
More |